BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36231904)

  • 1. Current Perspectives on the Determinants of Acceptability of Pre-Exposure Prophylaxis and Nonoccupational Post-Exposure Prophylaxis among People at Risk for HIV: A Scoping Review.
    Zhou L; Assanangkornchai S
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of Pre-Exposure Prophylaxis and Non-Occupational Post-Exposure Prophylaxis among Men Who Have Sex with Men in Guilin, China.
    Zhou L; Assanangkornchai S; Shi Z; Jiang F; Yang D; Shi W
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (Canada).
    Xia Y; Greenwald ZR; Milwid RM; Trottier C; Boissonnault M; Gaul N; Charest L; Landry G; N Zahedi N; Szabo J; Thomas R; Maheu-Giroux M
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):408-415. PubMed ID: 33136737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic.
    Braun HM; Walter C; Farrell N; Biello KB; Taylor JL
    J Addict Med; 2022 Nov-Dec 01; 16(6):678-683. PubMed ID: 36383918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Biomedical HIV Prevention Awareness and Use Among Black Transgender Women in the United States.
    Chandler CJ; Creasy SL; Adams BJ; Eaton LA; Bukowski LA; Egan JE; Friedman MR; Stall RD; Whitfield DL
    AIDS Behav; 2021 Sep; 25(9):2929-2940. PubMed ID: 33606134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study.
    Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Walach C; Placido T; Bogoch II
    AIDS Patient Care STDS; 2015 Aug; 29(8):431-6. PubMed ID: 26154174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
    Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-Related Training and Correlates of Knowledge, HIV Screening and Prescribing of nPEP and PrEP Among Primary Care Providers in Southeast United States, 2017.
    Henny KD; Duke CC; Geter A; Gaul Z; Frazier C; Peterson J; Buchacz K; Sutton MY
    AIDS Behav; 2019 Nov; 23(11):2926-2935. PubMed ID: 31172333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoprevention of Human Immunodeficiency Virus Infection.
    Yingling C; Broholm C; Stephenson S
    Nurs Clin North Am; 2020 Sep; 55(3):429-444. PubMed ID: 32762861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.
    Elliott T; Sanders EJ; Doherty M; Ndung'u T; Cohen M; Patel P; Cairns G; Rutstein SE; Ananworanich J; Brown C; Fidler S
    J Int AIDS Soc; 2019 Dec; 22(12):e25419. PubMed ID: 31850686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is non-occupational HIV Post Exposure Prophylaxis (nPEP) still used? An exploration of nPEP use since widespread availability of HIV PrEP.
    Woodward SC; Baynes AM; Tyson HA; Dunlop WA; Martin SJ
    Int J STD AIDS; 2022 Sep; 33(10):914-919. PubMed ID: 35853770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis.
    Huang YLA; Zhu W; Wiener J; Kourtis AP; Hall HI; Hoover KW
    Clin Infect Dis; 2022 Aug; 75(1):e1020-e1027. PubMed ID: 35040928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Community-Based HIV Prevention Organizations Say About Their Role in Biomedical HIV Prevention.
    Smith DK; Maier E; Betts J; Gray S; Kolodziejski B; Hoover KW
    AIDS Educ Prev; 2016 Oct; 28(5):426-439. PubMed ID: 27710082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the Impact of the COVID-19 Pandemic on HIV PrEP care: A Review and Synthesis of the Literature.
    Hong C
    AIDS Behav; 2023 Jul; 27(7):2089-2102. PubMed ID: 36459263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.
    King AR; Shah S; Randall LA; Frew PM; Spaulding A; ; Holloway IW
    BMC Infect Dis; 2022 Sep; 22(1):737. PubMed ID: 36104676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.
    Rosen JG; Zhang L; Pelaez D; Coleman JS; To C; Cooper L; Olatunde PF; Toomre T; Glick JL; Park JN
    AIDS Patient Care STDS; 2022 Aug; 36(8):313-320. PubMed ID: 35951445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
    Adeagbo O; Harrison S; Qiao S; Li X
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.
    Pacífico de Carvalho N; Mendicino CCP; Cândido RCF; Alecrim DJD; Menezes de Pádua CA
    AIDS Care; 2019 Oct; 31(10):1234-1240. PubMed ID: 31043069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.
    Biello KB; Edeza A; Salhaney P; Biancarelli DL; Mimiaga MJ; Drainoni ML; Childs ES; Bazzi AR
    AIDS Care; 2019 Oct; 31(10):1214-1220. PubMed ID: 30822103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.